Form D · Other
Phylos Bioscience, Inc.
Portland, OR · CIK 0001630986
Offering snapshot reported Dec 19, 2025 · SEC filing
- Reported sold
- $583K Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 9, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2025 | Initial | $583,418 | No comparison | 8 | SEC filing |
| Jan 23, 2025 | Amendment | $4,518,519 | $0vs Jan 24, 2024 | 25 | SEC filing |
| Nov 1, 2024 | Initial | $1,805,037 | No comparison | 8 | SEC filing |
| Jan 24, 2024 | Amendment | $4,518,519 | $0vs Jan 26, 2023 | 25 | SEC filing |
| Nov 7, 2023 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Feb 17, 2023 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jan 26, 2023 | Amendment | $4,518,519 | No comparison | 25 | SEC filing |
| Jan 24, 2022 | Amendment | $0 | No comparison | 0 | SEC filing |
| Dec 10, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 5, 2021 | Initial | $2,500,000 | No comparison | Not reported | SEC filing |
| Apr 19, 2021 | Amendment | $12,158,792 | $0vs May 5, 2020 | 33 | SEC filing |
| Jan 27, 2021 | Amendment | $4,518,519 | No comparison | 33 | SEC filing |
| May 5, 2020 | Amendment | $12,158,792 | $10,158,792vs May 10, 2019 | 33 | SEC filing |
| Jan 30, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 10, 2019 | Amendment | $2,000,000 | No comparison | 2 | SEC filing |
| Jan 3, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 26, 2017 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Sep 16, 2016 | Amendment | $1,430,000 | $1,180,000vs Sep 18, 2015 | 7 | SEC filing |
| Sep 18, 2015 | Amendment | $250,000 | $0vs Sep 17, 2015 | 1 | SEC filing |
| Sep 17, 2015 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Feb 3, 2015 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-567516
Source: Form D, filed Dec 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dylan Anderson | Executive |
| Scott Bowman | Executive |
| Timothy J Gregory | Director |
| Mowgli Holmes | Director, Executive |
| Nishan Karassik | Director, Executive |
| Stephen Lile | Executive |
| Mina Mishrikey | Director |
| David Patterson | Director |
| Barbara Peachey | Executive |
| Lada Rasochova, Ph D | Director |
| Dan Reiner | Director |
| Ralph J Risch | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2544 N.W. Nicolai Street Suite B 06
Portland, OR, 97210
Portland, OR, 97210